Article
CD133 as a target for colon cancer
1 Mar 2012
Abstract excerpt
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of translational research and providing relevant clinical implications in many tumour types, including colorectal cancer. The current failure of standard therapies is attributed to a small fraction of the primary cell population with stem-like characteristics, such as self-renewal and differentiation. Identification of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
